PATENT CLAIM ANALYSIS

Application Number: 15966433
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["424", "465000"]

Abstract:
This invention is directed in part to novel doses, dosage formulations, and routes of administration of such doses and dose formulations, said dose and dose formulations containing one or more copper chelators, for example, one or more trientine active agents, including trientine analogues, trientine salts, trientine prodrugs, and trientine derivatives, useful in the treatment of diseases, disorders and conditions, including in indications where copper may play a role.

Claim (Index 3):
The method of  claim 1  wherein the nephropathy is nephropathy leading to renal failure.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 91.0
- Lexical Diversity: 1.6875
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15096570', '14573211', '13037223', '11221298', '14029984']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8074992233416183
- 35 USC 102 Novelty (BERT): 0.5975286675078458
- Combined Prediction Score: 0.7865021677582411
- Mean Citation Score: 548.757518
- Max Citation Score: 672.3505
- Similarity Product: 409.1639143198728

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test